Cary Street Partners Investment Advisory’s Precigen PGEN Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-87,593	Closed	-$83K	–	691
2024 Q3	$83K	Hold	87,593	–	–	﹤0.01%	751
2024 Q2	$138K	Buy	87,593 +1,720	+2%	+$2.5K	0.01%	729
2024 Q1	$125K	Hold	85,873	–	–	0.01%	685
2023 Q4	$115K	Hold	85,873	–	–	0.01%	638
2023 Q3	$122K	Hold	85,873	–	–	0.01%	658
2023 Q2	$98.8K	Hold	85,873	–	–	0.01%	664
2023 Q1	$91K	Hold	85,873	–	–	0.01%	613
2022 Q4	$131K	Hold	85,873	–	–	0.01%	541
2022 Q3	$182K	Hold	85,873	–	–	0.02%	459
2022 Q2	$115K	Buy	+85,873	New	+$127K	0.01%	490
2021 Q1	–	Sell	-79,349	Closed	-$809K	–	394
2020 Q4	$809K	Buy	+79,349	New	+$514K	0.16%	135

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cary Street Partners Investment Advisory's PGEN Position: Q4 2024 in Review

Cary Street Partners Investment Advisory sold out of Precigen (PGEN) in Q4 2024, closing a stake of 87,593 shares — an estimated $83K sold.

Cary Street Partners Investment Advisory first reported a position in PGEN in Q4 2020 and held it in 11 quarters. The position peaked at $809K in Q4 2020. 133 funds tracked by Wall St. Rank hold PGEN as of Q4 2024.

Cary Street Partners Investment Advisory reported no remaining Precigen position as of Q4 2024 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 87,593 Precigen shares in Q4 2024, an estimated $83K.
Cary Street Partners Investment Advisory first reported a position in Precigen in Q4 2020 and held it in 11 quarters.
Cary Street Partners Investment Advisory's Precigen position peaked at $809K in Q4 2020.
133 funds tracked by Wall St. Rank held Precigen as of Q4 2024.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2024, filed 14 Feb 2025.